According to Altimmune's latest financial reports the company's current revenue (TTM ) is NZ$0.03 Million. a decrease over the revenue in the year 2023 that were of NZ$0.67 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | NZ$0.03 M | -94.74% |
2023 | NZ$0.67 M | -728.95% |
2022 | -NZ$0.11 Million | -101.66% |
2021 | NZ$6.45 M | -43.08% |
2020 | NZ$11.34 M | 31.69% |
2019 | NZ$8.61 M | -68% |
2018 | NZ$26.92 M | 45969.94% |
2017 | NZ$0.05 M | -98.23% |
2016 | NZ$3.3 M | -78.75% |
2015 | NZ$15.54 M | 19.54% |
2014 | NZ$13 M | -40.33% |
2013 | NZ$21.79 M | -28.77% |
2012 | NZ$30.6 M | -1.57% |
2011 | NZ$31.09 M | 14.26% |
2010 | NZ$27.21 M | -28.26% |
2009 | NZ$37.93 M | -33.12% |
2008 | NZ$56.71 M | 198.52% |
2007 | NZ$18.99 M | 880.65% |
2006 | NZ$1.93 M |